Clinical Trial Update: Assessment of T-cell Response and In-vitro Proof-of-concept of T-cell Engineering in Chronic ESKD Patients.

View source ↗

Summary

This clinical trial update describes evaluating T-cell response and in-vitro proof-of-concept of T-cell engineering in patients with chronic kidney disease, inc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Centre Hospitalier Régional d'Orléans | Conditions: Chronic Kidney Diseases | Status: RECRUITING